Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 33Tumor-Agnostic 25Thoracic 11Genitourinary 11Gastrointestinal 9Dermatologic 9Sarcoma 6Breast 5Endocrine 3Gynecologic 2Other hematologic neoplasm 1NET 1Lymphoid 1Head & Neck 1

Conditions

Lung Neoplasms 4Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 3Pituitary Neoplasms 2Liver Neoplasms 2Carcinoma, Neuroendocrine 2Adrenal Gland Neoplasms 2Thyroid Carcinoma, Anaplastic 1Paraganglioma 1Neurofibroma 1Neuroendocrine Tumors 1Neurilemmoma 1Meningioma 1Hypopituitarism 1Growth Hormone-Secreting Pituitary Adenoma 1Gastro-enteropancreatic neuroendocrine tumor 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Arteriovenous Malformations 1Anal Canal Carcinoma 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1Acromegaly 1

Interventions

Doxorubicin 4Sunitinib 3Radiosurgery 3Everolimus 3pembrolizumab 2exemestane 2Tamoxifen 2Specimen Handling 2Octreotide 2Magnetic Resonance Spectroscopy 2Fulvestrant 2Filgrastim 2Biopsy 2Bevacizumab 23-Iodobenzylguanidine 2tislelizumab 1surufatinib 1romidepsin 1regorafenib 1penpulimab 1pasireotide 1mercaptoundecahydrododecaborate 1lutetium Lu 177 dotatate 1lanreotide 1ganitumab 1folfirinox 1fludarabine phosphate 1epothilone B 1entrectinib 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Radiosurgery × Endocrine × Clear all
NCT04785287 2026-03-03

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

M.D. Anderson Cancer Center

Phase 1/2 Terminated
13 enrolled
EndocrineGastrointestinalThoracic

Adrenal Gland Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT02185443 2024-12-09

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

University of Sao Paulo

Phase 2 Recruiting
43 enrolled
EndocrineGastrointestinalNET

Anal Canal Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms, Neuroendocrine Tumors

NCT01185639 2019-11-29

Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer

Wake Forest University Health Sciences

Phase NA Completed
29 enrolled 8 charts
EndocrineGastrointestinalSarcomaThoracic

Adrenal Gland Neoplasms, Bone Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡